Recruiting

Urine Drug Screen

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT07192887

Conditions

Urine Specimen Collection

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Study Details

Brief summary:

To develop and validate a urine drug screen to detect thebaine.

Conditions

Urine Specimen Collection

Study ID

NCT07192887

Start date

May 7, 2025

Status verified date

Sep, 2025

Completion date

Mar, 2027

Anticipated

Primary completion date

Mar, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Male or female
  • Ages 18-65
  • Healthy

Exclusion Criteria:

  • Allergy to poppy seeds, or any of the related food stuffs used in the study
  • Celiac disease or gluten sensitivity
  • Ongoing or opioid use in the past 6 months
  • History of renal or hepatic disease or dysfunction
  • Inability or unwillingness to give repeated urine specimens
  • Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study
  • Non-English speakers (due to study materials being in English)
  • BMI greater than 30
  • Antibiotic use in the previous 2 months
  • Recent ingestion of poppy seeds from the previous 7 days

Study Design

Enrollment

20 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Validate thebaine urine screen [ Time Frame: Enrollment to 48 hours after enrollment ]

Central Contacts and Locations

Central contacts

Charlotte Walter, MD

513-636-4408charlotte.walter@cchmc.org

Locations

Cincinnati Children's Hospital Medical Center

Recruiting

Cincinnati, Ohio, United States, 45229

Contacts

Charlotte Walter, MD

513-636-4408charlotte.walter@cchmc.org

More Information

Sponsor

Children's Hospital Medical Center, Cincinnati

Last update posted

Sep 25, 2025

Last verified

Sep, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2025-09-25.